The U.S. Food and Drug Administration (FDA) has approved ranibizumab injection (Susvimo, 100 mg/mL; Genentech) for the ...
The goal is to educate the public and professionals about AMD and support patients and families affected by vision impairment ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback